MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Replicate Results from First GLP-1 Study Following CRO Contract Award for 12-Week Chronic Human Study
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the hiring of a contract research organization (“CRO”) that will be responsible for overseeing the execution of the company’s upcoming chronic human…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Expanding Solutions to Significant Untapped Market
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically working with partners to help clients facilitate green energy transition and improvements. “Correlate Energy is expanding…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors
McEwen Mining’s (NYSE: MUX) (TSX: MUX) share price has shown a remarkable gain of 62.1% over the last 12 weeks, indicating strong momentum and robust performance in the market. “This trend of sustained positive momentum…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
InMed (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. The company recently released several critical updates regarding its INM-089 therapy…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Continues ‘Strong Collaboration’ with New $2.9M Orders from European Governments
SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, today announced the receipt of new orders from European governments. These orders are valued at $2.9 million and…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Pioneering Battery Exchange Program for Qualifying Class 1 EV Cargo Van Customers
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing POWER BOOST, a pioneering vehicle battery exchange program for current Class 1 EV cargo van customers. According to the announcement, POWER BOOST allows…
-
SenesTech Inc. (NASDAQ: SNES) Scores Major Client with Evolve(TM) Deployment in the U.S. Virgin Islands
SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the deployment of its Evolve(TM) flagship product to the U.S. Virgin…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Subsidiary Debuts Emergency Response Management Platform
FingerMotion (NASDAQ: FNGR), a mobile services and data company, through its contractually controlled subsidiary, Shanghai JuiGe Information Technology Co. Ltd. is offering advanced solutions for nationwide emergency response management. According to the announcement, the company…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that human pilot study #2, GLP-1-H24-2, has now completed all dosing. The final DehydraTECH study arm used a Rybelsus(R) composition processed…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Approximately $825K Vehicle Order for B4 EV Chassis Cabs
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has reached an agreement to sell five all-electric Class 4 Bollinger B4 commercial trucks to Spencer Manufacturing, which will…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Effect 1-for-20 Reverse Stock Split
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced…
-
New European EM Contracts Give SuperCom Ltd. (NASDAQ: SPCB) Platform Broader Horizon in Growing Drive for Public Safety
Security solutions innovator SuperCom (NASDAQ: SPCB) is a growing provider of electronic monitoring technologies for a variety of primarily governmental client needs. Applications include the supervision of individuals in criminal cases who have qualified for home-based detention…
-
Correlate Energy Corp. (CIPI) Subsidiary Enters Key Partnership in Nation’s First Microgrid Utility
The microgrid energy distribution market is expected to grow at a CAGR of 18.5 percent during the next five years to a valuation of $87.8 billion dollars, according to analysts at MarketsandMarkets Research, reflecting a rising…
-
SenesTech Inc. (NASDAQ: SNES) Offering a Solution to the World Rodent Problem with its One-Of-A-Kind Fertility Control Technology
In the fiscal year 2023, calls to 3-1-1 in Washington D.C. regarding rat sightings and complaints hit 16,391, up from 8,107 in 2020 (https://ibn.fm/0j62f). For the state government, the hotline was set up as a…
-
D-Wave Quantum Inc. (NYSE: QBTS) Announces Partnership Extension and Launch of New Hybrid Quantum Solver
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, has announced an extension of its partnership with Aramco, a global leader in energy and chemicals, to address geophysical optimization challenges using…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused…
-
Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment
Clene (NASDAQ: CLNN), along with its subsidiary Clene Nanomedicine Inc., a biopharmaceutical company specializing in mitochondrial health to address neurological diseases like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently revealed new preliminary data…
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it has expanded its e-commerce development program in China through a new agreement with a leading Chinese healthcare and nutritional products marketing and distribution…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q1 2024 Financial Reports, Business Update
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting on…
-
SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
SOBRsafe (NASDAQ: SOBR) provides next-generation transdermal alcohol detection technology, which simplifies the alcohol detection process. The proprietary technology combines an NIAAA-awarded gas sensor with proprietary algorithms to capture alcohol vapor emitted through pores, detecting alcohol 2-3x…
-
Formal Study on EM Benefits Provides Substance to Promised Potential of SuperCom Ltd.’s (NASDAQ: SPCB) Flagship Electronic Monitoring Technology
As societies worldwide grapple with curtailing criminal behavior, they might well take inspiration from a study of Sweden’s electronic monitoring (“EM”) program providing a remote, automated alternative to incarceration for the lowest tier of criminal…
-
MissionIRNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’
Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Hosts British Columbia Government Officials at Its Quantum Engineering Center of Excellence
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, announced that Jagrup Brar, British Columbia (“B.C.”) Minister of State for…
-
Annovis Bio Inc. (NYSE: ANVS) Announces Results From Phase II/III Buntanetap Study for the Treatment of Alzheimer’s Disease
June is Alzheimer’s & Brain Awareness Month, a time dedicated to raising awareness about Alzheimer’s disease and other forms of dementia, as well as the importance of brain health. Even though the month is almost…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Filing of Provisional Patent Covering Manufacturing Process of New Solid Forms of Buntanetap
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), is announcing the filing of a provisional patent. This patent covers the manufacturing process…
-
Clene Inc. (NASDAQ: CLNN) Reveals Important Findings From HEALEY ALS Platform Trial
Clene (NASDAQ: CLNN), through its wholly owned subsidiary, Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company dedicated to enhancing mitochondrial health and safeguarding neuronal function to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (“ALS”)…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Second Round of Dosing for Human Pilot Study #2; Set to Complete Third Study Arm in Early July
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2, GLP-1-H24-2. The study aims to evaluate the…
-
MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Subsidiary Secures EPA Certification for Class 4 EV Commercial Trucks
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, an electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has received its Certificate of Conformity from the Environmental Protection Agency (“EPA”) for its…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Featured in The Stock2Me Podcast
D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems within logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces More than $3M in Orders from European Governments
SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, is announcing the receipt of orders from European governments. The orders, valued at over $3 million, are expected…
-
D-Wave Quantum Inc. (NYSE: QBTS) Featured in Wall Street Journal Article About Tackling Real-World Optimization Problems with Quantum
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced that it has been featured in a Wall Street Journal article…
-
SuperCom Ltd.’s (NASDAQ: SPCB) Strategic Innovations Drive Record Growth and Public Safety Progress
SuperCom (NASDAQ: SPCB), a global leader in secured solutions for the e-government, IoT, and cybersecurity sectors, offers a comprehensive suite of field-proven RFID and GPS tracking technologies. SuperCom’s services span various industries, including security, public…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Unveils New Hybrid Quantum Solver Designed to Simplify and Accelerate Successful Quantum Technology Adoption
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has unveiled a new hybrid quantum solver for addressing nonlinear problems. The…
-
MissionIRNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Issues Reminder for Warrant Holders Regarding Expiration Date
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has released a reminder for holders of outstanding common share purchase warrants issued on July 8, 2022; the company is reminding…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), will be presenting results from its latest Alzheimer’s study at the Alzheimer’s Association International…
-
Clene Inc. (NASDAQ: CLNN) CEO and CFO Present Corporate Updates and Future Plans at 72nd Emerging Growth Conference
Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently participated in the 72nd Emerging…
-
Jump in Solar Energy Adoption Facilitated by Distributed Energy Solutions of Correlate Energy Corp. (CIPI)
Electric utilities have become the engine moving solar energy adoption in the United States, accounting for 11.8 gigawatts of new energy capacity in the first three months of 2024, according to a June 5 report…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Management Presents During Chardan Transport Platform Tech Series
Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping, participated…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial